Literature DB >> 2313116

High-affinity binding and lack of growth-promoting activity of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) in a human epidermal cell line.

E Gross1, T Ruzicka, B von Restorff, W Stolz, K N Klotz.   

Abstract

The arachidonic acid metabolite 12-hydroxyeicosatetraenoic acid (12-HETE) is assumed to play an important role in skin physiology and pathophysiology. Specifically, it has recently been discussed as a growth promoting agent in keratinocytes. Our aim was to find out whether epidermal cells possess specific receptors for 12-HETE which would mediate the effects of this eicosanoid in skin, including the putative growth stimulating activity. We could identify specific binding sites for 12(S)-HETE on the human epidermal cell line SCL-II. The analysis of binding data revealed a single class of binding sites with a Kd of 2,6 nM and a Bmax of 216,000 sites per cell. The binding was saturable, readily reversible, and specific for 12(S)-HETE with lower affinities for other monoHETE. We failed to detect any significant proliferative activity of 12(S)-HETE in the same epidermal cell line, although we applied three independent methods for evaluation of cell growth and used a concentration of 12(S)-HETE which should enable an optimal receptor occupancy. Thus, epidermal cells possess high-affinity 12(S)-HETE binding sites which are likely to be involved in the effects of this eicosanoid in epidermis. However, biologic effects other than direct growth stimulation seem to be transduced by 12(S)-HETE receptors in epidermal cells which need further investigation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313116     DOI: 10.1111/1523-1747.ep12874543

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  12-Hydroxyeicosatetraenoic acid (12-HETE) is a chemotactic stimulus for epidermal cells.

Authors:  R Hein; E Gross; T Ruzicka; T Krieg
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

Review 2.  Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid.

Authors:  William S Powell; Joshua Rokach
Journal:  Biochim Biophys Acta       Date:  2014-10-29

Review 3.  12-lipoxygenases and 12(S)-HETE: role in cancer metastasis.

Authors:  K V Honn; D G Tang; X Gao; I A Butovich; B Liu; J Timar; W Hagmann
Journal:  Cancer Metastasis Rev       Date:  1994-12       Impact factor: 9.264

4.  SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.

Authors:  L Kemény; T Ruzicka
Journal:  Agents Actions       Date:  1991-03

5.  Dithranol-induced down-regulation of 12(S)-hydroxyeicosatetraenoic acid [12(S)-HETE] receptors in a human epidermal cell line.

Authors:  L Kemény; E Gross; P Arenberger; T Ruzicka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

6.  Lipoxygenase metabolites of arachidonic and linoleic acids modulate the adhesion of tumor cells to endothelium via regulation of protein kinase C.

Authors:  B Liu; J Timar; J Howlett; C A Diglio; K V Honn
Journal:  Cell Regul       Date:  1991-12

Review 7.  Fatty acid modulation of tumor cell-platelet-vessel wall interaction.

Authors:  Y Q Chen; B Liu; D G Tang; K V Honn
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

8.  12(S)-hydroxyeicosatetraenoic acid and 13(S)-hydroxyoctadecadienoic acid regulation of protein kinase C-alpha in melanoma cells: role of receptor-mediated hydrolysis of inositol phospholipids.

Authors:  B Liu; W A Khan; Y A Hannun; J Timar; J D Taylor; S Lundy; I Butovich; K V Honn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

9.  P450 Eicosanoids and Reactive Oxygen Species Interplay in Brain Injury and Neuroprotection.

Authors:  Xuehong Liu; Catherine M Davis; Nabil J Alkayed
Journal:  Antioxid Redox Signal       Date:  2017-04-20       Impact factor: 8.401

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.